Calamos Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,379
| Closed | -$829K | – | 962 |
|
|
2023
Q4 | $829K | Buy |
+16,379
| New | +$829K | ﹤0.01% | 649 |
|
|
2023
Q1 | – | Sell |
-7,026
| Closed | -$265K | – | 1145 |
|
|
2022
Q4 | $265K | Sell |
7,026
-10,093
| -59% | -$381K | ﹤0.01% | 907 |
|
|
2022
Q3 | $757K | Buy |
+17,119
| New | +$757K | ﹤0.01% | 946 |
|
|
2019
Q3 | – | Sell |
-3,150
| Closed | -$202K | – | 726 |
|
|
2019
Q2 | $202K | Buy |
+3,150
| New | +$202K | ﹤0.01% | 690 |
|
|
2016
Q2 | – | Sell |
-64,918
| Closed | -$2.63M | – | 616 |
|
|
2016
Q1 | $2.63M | Sell |
64,918
-297,107
| -82% | -$12M | 0.02% | 411 |
|
|
2015
Q4 | $22.4M | Buy |
362,025
+223,865
| +162% | +$13.9M | 0.14% | 190 |
|
|
2015
Q3 | $5.58M | Hold |
138,160
| – | – | 0.04% | 330 |
|
|
2015
Q2 | $7.95M | Buy |
138,160
+93,630
| +210% | +$5.39M | 0.05% | 307 |
|
|
2015
Q1 | $2.84M | Buy |
44,530
+37,390
| +524% | +$2.38M | 0.02% | 441 |
|
|
2014
Q4 | $441K | Sell |
7,140
-7,710
| -52% | -$476K | ﹤0.01% | 603 |
|
|
2014
Q3 | $577K | Buy |
14,850
+4,700
| +46% | +$183K | ﹤0.01% | 561 |
|
|
2014
Q2 | $350K | Buy |
+10,150
| New | +$350K | ﹤0.01% | 602 |
|